The very name of this journal speaks volumes about the depth of molecular-level questions it explores.

This marks a breakthrough moment for our foundation — the first step towards building an independent research program aimed at understanding the role of the endocannabinoid system and gut microbiota in type 1 diabetes.

The open-access publication requires a fee of 1,950 Swiss francs. We are therefore launching a fundraiser to help cover the publication costs and support our ongoing mission.

Support our mission here – every contribution makes a difference

Thank you for your support. Together, we can push the boundaries of knowledge and open new therapeutic possibilities for people living with type 1 diabetes.